149 related articles for article (PubMed ID: 34757840)
1. Viral Fitness and Antigenic Determinants of Porcine Parvovirus at the Amino Acid Level of the Capsid Protein.
Streck AF; Canal CW; Truyen U
J Virol; 2022 Jan; 96(2):e0119821. PubMed ID: 34757840
[TBL] [Abstract][Full Text] [Related]
2. Identification of a dominant linear epitope on the VP2 capsid protein of porcine parvovirus and characterization of two monoclonal antibodies with neutralizing abilities.
Liu Y; Wang J; Chen Y; Wang A; Wei Q; Yang S; Feng H; Chai S; Liu D; Zhang G
Int J Biol Macromol; 2020 Nov; 163():2013-2022. PubMed ID: 32931829
[TBL] [Abstract][Full Text] [Related]
3. Generation of recombinant porcine parvovirus virus-like particles in Saccharomyces cerevisiae and development of virus-specific monoclonal antibodies.
Tamošiūnas PL; Petraitytė-Burneikienė R; Lasickienė R; Akatov A; Kundrotas G; Sereika V; Lelešius R; Žvirblienė A; Sasnauskas K
J Immunol Res; 2014; 2014():573531. PubMed ID: 25045718
[TBL] [Abstract][Full Text] [Related]
4. Study of the virulence and cross-neutralization capability of recent porcine parvovirus field isolates and vaccine viruses in experimentally infected pregnant gilts.
Zeeuw EJL; Leinecker N; Herwig V; Selbitz HJ; Truyen U
J Gen Virol; 2007 Feb; 88(Pt 2):420-427. PubMed ID: 17251558
[TBL] [Abstract][Full Text] [Related]
5. The immunogenicity of the virus-like particles derived from the VP2 protein of porcine parvovirus.
Hua T; Zhang D; Tang B; Chang C; Liu G; Zhang X
Vet Microbiol; 2020 Sep; 248():108795. PubMed ID: 32827923
[TBL] [Abstract][Full Text] [Related]
6. Large-scale manufacture of VP2 VLP vaccine against porcine parvovirus in Escherichia coli with high-density fermentation.
Wang J; Liu Y; Chen Y; Wang A; Wei Q; Liu D; Zhang G
Appl Microbiol Biotechnol; 2020 May; 104(9):3847-3857. PubMed ID: 32130468
[TBL] [Abstract][Full Text] [Related]
7. Influence of minor displacements in loops of the porcine parvovirus VP2 capsid on virus-like particles assembly and the induction of antibody responses.
Pan Q; He K; Wang Y; Wang X; Ouyang W
Virus Genes; 2013 Jun; 46(3):465-72. PubMed ID: 23430711
[TBL] [Abstract][Full Text] [Related]
8. Porcine parvovirus VP1/VP2 on a time series epitope mapping: exploring the effects of high hydrostatic pressure on the immune recognition of antigens.
de Souza AR; Yamin M; Gava D; Zanella JRC; Gatti MSV; Bonafe CFS; de Lima Neto DF
Virol J; 2019 Jun; 16(1):75. PubMed ID: 31159841
[TBL] [Abstract][Full Text] [Related]
9. Genetic variability of porcine parvovirus isolates revealed by analysis of partial sequences of the structural coding gene VP2.
Soares RM; Cortez A; Heinemann MB; Sakamoto SM; Martins VG; Bacci M; de Campos Fernandes FM; Richtzenhain LJ
J Gen Virol; 2003 Jun; 84(Pt 6):1505-1515. PubMed ID: 12771420
[TBL] [Abstract][Full Text] [Related]
10. Capsid assembly is regulated by amino acid residues asparagine 47 and 48 in the VP2 protein of porcine parvovirus.
Wang J; Liu Y; Chen Y; Zhang T; Wang A; Wei Q; Liu D; Wang F; Zhang G
Vet Microbiol; 2021 Feb; 253():108974. PubMed ID: 33433338
[TBL] [Abstract][Full Text] [Related]
11. High rate of viral evolution in the capsid protein of porcine parvovirus.
Streck AF; Bonatto SL; Homeier T; Souza CK; Gonçalves KR; Gava D; Canal CW; Truyen U
J Gen Virol; 2011 Nov; 92(Pt 11):2628-2636. PubMed ID: 21795474
[TBL] [Abstract][Full Text] [Related]
12. Perspectives on the Evolution of Porcine Parvovirus.
Oh WT; Kim RY; Nguyen VG; Chung HC; Park BK
Viruses; 2017 Jul; 9(8):. PubMed ID: 28933737
[TBL] [Abstract][Full Text] [Related]
13. [Immune Response of Recombinant Pseudorabies Virus rPRV-VP2 Expressing VP2 Gene of Porcine Parvovirus in Mice].
Fu P; Pan X; Han Q; Yang X; Zhu Q; Guo X; Zhang Y; Chen H
Bing Du Xue Bao; 2016 Mar; 32(2):195-202. PubMed ID: 27396164
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology and evolution of porcine parvoviruses.
Streck AF; Canal CW; Truyen U
Infect Genet Evol; 2015 Dec; 36():300-306. PubMed ID: 26453771
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
[TBL] [Abstract][Full Text] [Related]
16. [Co-expression of CSFV T cell epitope E290 peptide and PPV VP2 protein in Lactobacillus casei and determination of specific antibodies in immunized mice].
Xu YG; Cui LC; Ge JW; Zhao LL; Li YJ
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):667-72. PubMed ID: 17944369
[TBL] [Abstract][Full Text] [Related]
17. A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine.
Chen Y; Guo W; Xu Z; Yan Q; Luo Y; Shi Q; Chen D; Zhu L; Wang X
Virol J; 2011 Jun; 8():307. PubMed ID: 21679423
[TBL] [Abstract][Full Text] [Related]
18. [Construction and immunogenicity of recombinant porcine parvovirus-like particles with somatostatin].
Zhang X; Zheng Q; Chen J; Xue G; Hou H; Hou J
Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1057-67. PubMed ID: 21090109
[TBL] [Abstract][Full Text] [Related]
19. Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2.
Pan Q; He K; Huang K
Vaccine; 2008 Apr; 26(17):2119-26. PubMed ID: 18378364
[TBL] [Abstract][Full Text] [Related]
20. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2.
Liu G; Qiao X; Chang C; Hua T; Wang J; Tang B; Zhang D
Viral Immunol; 2020; 33(6):444-456. PubMed ID: 32255758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
